Circulating antibodies against bacterial wall products: are there arguments for early immunosuppression? (Q38072225)

28 August 2017

1 reference

title

Circulating antibodies against bacterial wall products: are there arguments for early immunosuppression? (English)

1 reference

28 August 2017

1 reference

Florian Rieder

1

1 reference

28 August 2017

Subra Kugathasan

series ordinal

2

1 reference

28 August 2017

publication date

1 January 2012

1 reference

28 August 2017

1 reference

28 August 2017

volume

30 Suppl 3

1 reference

28 August 2017

page(s)

55-66

1 reference

Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort

28 August 2017

cites work

1 reference

Phenotype at diagnosis predicts recurrence rates in Crohn's disease

21 January 2018

1 reference

Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease

21 January 2018

1 reference

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

21 January 2018

1 reference

Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen

21 January 2018

1 reference

Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study

21 January 2018

1 reference

Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates

21 January 2018

1 reference

Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease

21 January 2018

1 reference

Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients.

21 January 2018

1 reference

Natural history of pediatric Crohn's disease: a population-based cohort study

21 January 2018

1 reference

Does anti-TNF therapy reduce the requirement for surgery in ulcerative colitis? A systematic review

21 January 2018

1 reference

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

21 January 2018

1 reference

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

21 January 2018

1 reference

Review article: the burden of hepatic encephalopathy

21 January 2018

1 reference

Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease

21 January 2018

1 reference

Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study.

21 January 2018

1 reference

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries

21 January 2018

1 reference

Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study

21 January 2018

1 reference

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

21 January 2018

1 reference

The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

21 January 2018

1 reference

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization

21 January 2018

1 reference

A meta-analysis of the therapeutic effects of tumor necrosis factor-α blockers on ulcerative colitis

21 January 2018

1 reference

Predictors of early response to infliximab in patients with ulcerative colitis

21 January 2018

1 reference

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

21 January 2018

1 reference

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

21 January 2018

1 reference

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.

21 January 2018

1 reference

Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older?

21 January 2018

1 reference

Risk factors and characteristics of extent progression in ulcerative colitis.

21 January 2018

1 reference

The natural history of pediatric ulcerative colitis: a population-based cohort study

21 January 2018

1 reference

Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis

21 January 2018

1 reference

Laboratory markers in IBD: useful, magic, or unnecessary toys?

21 January 2018

1 reference

Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans

21 January 2018

1 reference

Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease

21 January 2018

1 reference

Anti-glycan antibodies as biomarkers for diagnosis and prognosis

21 January 2018

1 reference

Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype

21 January 2018

1 reference

Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior

21 January 2018

1 reference

Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases

21 January 2018

1 reference

Serologic antiglycan antibodies in inflammatory bowel disease.

21 January 2018

1 reference

Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease

21 January 2018

1 reference

Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing

21 January 2018

1 reference

Longitudinal studies of patients with ANCA vasculitis demonstrate concurrent reactivity to complementary PR3 protein segments cPR3m and cPR3C and with no reactivity to cPR3N

21 January 2018

1 reference

Cellular immune responses and pathogenesis in c-ANCA positive vasculitides

21 January 2018

1 reference

Colonic bacteria express an ulcerative colitis pANCA-related protein epitope

21 January 2018

1 reference

A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease

21 January 2018

1 reference

Serologic markers in inflammatory bowel disease

21 January 2018

1 reference

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression

21 January 2018

1 reference

Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

21 January 2018

1 reference

High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study

21 January 2018

1 reference

Bacterial flagellin is a dominant antigen in Crohn disease.

21 January 2018

1 reference

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease

21 January 2018

1 reference

Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.

21 January 2018

1 reference

Increased immune reactivity predicts aggressive complicating Crohn's disease in children

21 January 2018

1 reference

Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease

21 January 2018

1 reference

Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis

21 January 2018

1 reference

Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation

21 January 2018

1 reference

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis

21 January 2018

1 reference

Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study

21 January 2018

1 reference

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

21 January 2018

1 reference

New serological biomarkers of inflammatory bowel disease

21 January 2018

1 reference

Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort

21 January 2018

1 reference

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

21 January 2018

1 reference

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

21 January 2018

1 reference

NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans

21 January 2018

1 reference

Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?

21 January 2018

1 reference

Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation

21 January 2018

1 reference

Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study

21 January 2018

1 reference

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease

21 January 2018

1 reference

Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

21 January 2018

1 reference

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

21 January 2018

1 reference

Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease

21 January 2018

1 reference

Long-Term Observation of the Perinuclear Anti-Neutrophil Cytoplasmic Antibody Status in Ulcerative Colitis Patients

21 January 2018

1 reference

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

21 January 2018

1 reference

Utility of serum antibodies in determining clinical course in pediatric Crohn's disease

21 January 2018

1 reference

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

21 January 2018

1 reference

Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis

21 January 2018

1 reference

Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis

21 January 2018

1 reference

High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease

21 January 2018

1 reference

Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease

21 January 2018

1 reference

Serological responses to microbial antigens in celiac disease patients during a gluten-free diet

21 January 2018

1 reference

Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

21 January 2018

1 reference

Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis

21 January 2018

1 reference

NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.

21 January 2018

1 reference

The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis.

21 January 2018

1 reference

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

21 January 2018

1 reference

Combination of genetic and quantitative serological immune markers are associated with complicated Crohnʼs disease behavior

21 January 2018

1 reference

Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease

21 January 2018

1 reference

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

21 January 2018

1 reference

Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohnʼs disease patients: A project of the European Collaborative Study Group on Inflammatory Bowel Disease

21 January 2018

1 reference

Infliximab prevents Crohn's disease recurrence after ileal resection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000342603

1 reference

28 August 2017

1 reference